Shares in Value Logo
Product Review Img Vertical

Date : 19/02/2021

Learn why Cochlear’s (ASX:COH) statutory profit surged 50% in first half

Cochlear is a medical device company that designs, manufactures and supplies the Nucleus cochlear implant, the Hybrid electro-acoustic implant and the Baha bone conduction implant. The Chiclear share price has been very volatile throughout the pandemic. We have witnessed the share price go as high as $238 and as low as $154 during the past 1 year.

This morning, Cochlear shares have been upbeat surging over 8% on the back of their financial result for the first half of FY2021. Following the shutdowns due to Covid19, Cochlear has experienced improving momentum across the half year as surgeries have recovered. The USA, Japan, Kora, and China have been the regions with strong growth. The statutory net profit increased 50% to $236.2 million for the half ended December 2020. This is compared to the $157.7 million the previous corresponding period. The increase is largely due to one off gains such as – $59 million in patent litigation related tax, $34.7 million in innovation fund gains, $17.2 million in Covid19 government assistance, etc.

Following the growth in net profits, Cochlear has re-introduced dividend and is paying out 60% of its net profits as an interim dividend of $1.15 a share. Cochlear shares closed today at $221.68 a share. The firm expects continued recovery in surgery rates, but there are challenges as the reemergence of the virus is forcing lockdowns in other parts of the world. Australia’s economy in 2021 is looking bright and so will most developed economies as we emerge from the crisis. Cochlear is expected to deliver underlying net profit after tax of $225 million – $245 million for FY2021 full year – representing about 46% – 59% increase over FY2020.

Looking for Income Stocks?

Income stocks are potentially one of the hardest to pick as there are a lot of factors that need to be considered – from industry tailwinds to financial health of the individual stocks, and a lot of little things in between them. Several ASX listed stocks have also cut dividends in light of the challenges posed by the pandemic.The low interest rate environment brings income stocks to the forefront for most investors. With the earnings season bringing back dividends in most industries, Shares in Value research team have picked their top 3 ASX income stocks to buy and it can be downloaded for free!

Are You Looking To Buy The Best Stocks In 2022?

Stay on top of upcoming market trends! Whether you are an SMSF investor or a young investor with your portfolio, we cover a wide range of stocks across all sectors, including mining, financials, industrials, real estate, technology, health and biotech, etc. It will give you an edge to invest and trade ASX listed stocks across large, mid and small caps with an advantage.

Get stock tips with our Market Experts. We help self-directed investors and self-managed super funds (SMSF) make smarter investment decisions and get better returns. Fill in your details and download your free Report instantly for Top 3 Dividend Stocks to buy in 2022!

 

Top 5 ASX Stocks
to Buy for Capital Growth in 2022

asx landing page
The hardest part to finding growth stocks is having an ability to understand the finer details of these companies from their valuations through to first mover advantage and having key factors on hand to make informed investment decisions.

Our experts take the guesswork out.

Download Your Free Report

By downloading this report you agree to the TERMS AND CONDITIONS and our PRIVACY POLICY

Scroll to Top

Login

By submitting this form, I agree to the TERMS AND CONDITIONS and PRIVATE POLICY

Please fill in your details to download the free dividend shares report.

We will send your report instantly. Please put your correct email address and phone number.